Kexing Biopharm Co., Ltd. (SHA:688136)

Kexing Biopharm Revenue

Kexing Biopharm had revenue of 447.17M CNY in the quarter ending September 30, 2025, with 60.65% growth. This brings the company's revenue in the last twelve months to 1.52B, up 14.15% year-over-year. In the year 2024, Kexing Biopharm had annual revenue of 1.41B with 11.75% growth.

• Revenue (ttm): 1.52B
• Revenue Growth: +14.15%
• P/S Ratio: 4.40
• Revenue / Employee: 1.60M
• Employees: 947
• Market Cap: 6.66B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.41B	147.89M	11.75%
Dec 31, 2023	1.26B	-56.84M	-4.32%
Dec 31, 2022	1.32B	30.70M	2.39%
Dec 31, 2021	1.29B	64.88M	5.32%
Dec 31, 2020	1.22B	29.52M	2.48%